New directions in adaptive designs

Statistical Science

Volumn 11, Issue 2, 1996, Pages 137-149

  Rosenberger, William F ^a,b  

^a UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical trials; Dose response studies; Ethics; Quantile estimation; Random walks; Randomized play the winner rule; Urn models

Indexed keywords

EID: 0000364767     PISSN: 08834237     EISSN: None     Source Type: Journal    
DOI: 10.1214/ss/1038425657     Document Type: Article

References (60)

1. Andersen, J., Faeies, D. and Tamura, R. (1994). A randomized play-the-winner design for multi-arm clinical trials. Comm. Statist. A-Theory Methods 23 309-323.
2. Anderson, T. W., McCarthy, P. J. and Tukey, J. W. (1946). “Staircase” method of sensitivity testing. Naval Ordinance Report 65-46, Statistical Research Group, Princeton.
3. Anscombe, F. (1963). Sequential medical trials. J. Amer. Statist. Assoc. 58 365-384.
4. Athreya, K. B. and Karlin, S. (1967). Limit theorems for the split times of branching processes. Journal of Mathematics and Mechanics 17 257-277.
5. Athreya, K. B. and Karlin, S. (1968). Embedding of urn schemes into continuous time Markov branching processes and related limit theorems. Ann. Math. Statist. 39 1801-1817.
6. Bartlett, R. H., Roloff, D. W., Cornell, R. G., Andrews, a. F., Dillon, P. W. and Zwischenberger, J. B. (1985). Extracor-poreal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics 76 479-487.
7. Begg, C. B. (1990). On inferences from Wei’s biased coin design for clinical trials, with discussion. Biometrika 77 467-484.
8. Byar, D. p., Simon, R. M., Friedewald, W. T., Sohlesselman, J. J., DeMets, D. L., Ellenberg, J. H., Gail, M. H. and Ware, J. H. (1976). Randomized clinical trials-perspectives on some recent ideas. New England Journal of Medicine 295 74-80.
9. Chevret, S. (1993). The continual reassessment method in cancer phase I clinical trials: a simulation study. Statistics in Medicine 12 1093-1108.
10. Coad, D. S. (1991). Sequential tests for an unstable response variable. Biometrika 78 113-121.
11. Coad, D. s. (1992). A comparative study of some data-dependent allocation rules for Bernoulli data. J. Statist. Comput. Simulation 40 219-231.
12. Colton, T. (1963). A model for selecting one of two medical treatments. J. Amer. Statist. Assoc. 58 388-401.
13. Connor, E. M., Sperling, R. s., Gelber, R., Kiselev, P., Scott, G., O’Sullivan, M. J., Vandyke, R., Bey, M., Shearer, W., Jacobson, R. L., Jiminez, E., O’Neill, E., Bazin, B., Del-fraissy, J., Culnane, M., Coombs, R., Elkins, M., Moye, J., Stratton, P. and Balsley, J. (1994). Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New England Journal of Medicine 331 1173-1180. (Report written for the Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.)
14. Cornfield, J., Halperin, M. and Greenhouse, s. W. (1969). An adaptive procedure for sequential clinical trials. J. Amer. Statist. Assoc. 64 759-770.
15. Derman, C. (1957). Nonparametric up and down experimentation. Ann. Math. Statist. 28 795-798.
16. Dixon, W. J. and Mood, A. M. (1948). A method for obtaining and analyzing sensitivity data. J. Amer. Statist. Assoc. 43 109-126.
17. Durham, s. D. and Flournoy, N. (1994). Random walks for quantile estimation. In Statistical Decision Theory and Related Topics V (S. S. Gupta and J. O. Berger, eds.) 467-476. Springer, New York.
18. Durham, s. D., Flournoy, N. and Montazer-Haghighi, A. A. (1993). Up-and-down designs. In Computer Science and Statistics: Interface (M. E. Tarter and M. D. Lock, eds.) 25 375-384. Interface Foundation of North America, Berkeley.
19. Durham, s. D., Flournoy, N. and Rosenberger, W. F. (1996). A random walk rule for phase I clinical trials. Biometrics. To appear.
20. Farewell, V. T., Viveros, R. and Sprott, D. A. (1993). Statistical consequences of an adaptive treatment allocation in a clinical trial. Canad. J. Statist. 21 21-27.
21. Flehinger, B. J. and Louis, T. A. (1971). Sequential treatment allocation in clinical trials. Biometrika 58 419-426.
22. Flournoy, N. (1993). A clinical experiment in bone marrow transplantation: estimating a percentage point of a quantal response curve. In Case Studies in Bayesian Statistics (C. Gastonis, J. S. Hodges, R. E. Kass and N. D. Singpurwalla, eds.) 324-336. Springer, New York.
23. Flournoy, N., Durham, s. D. and Rosenberger, W. F. (1995). Toxicity in sequential dose-response studies. Sequential Analysis 14 217-227.
24. Flournoy, N. and Rosenberger, W. F., eds. (1995). Adaptive Designs. IMS, Hayward, CA.
25. Gantmacher, F. R. (1959). Matrix Theory 2. Chelsea, New York.
26. Gastonis, C. and Greenhouse, J. B. (1992). Bayesian methods for phase I clinical trials. Statistics in Medicine 11 1377-1389.
27. Gooley, T. A., Martin, P. J., Fisher, L. D. and Pettinger, M. (1994). Simulation as a design tool for phase I/II clinical trials: an example from bone marrow transplantation. Controlled Clinical Trials 15 450-462.
28. Hardwick, J. (1989). Comment: recent progress in clinical trial designs that adapt for ethical purposes. Statist. Sci. 4 327-336.
29. Kalbfleisch, J. D. and Prentice, R. L. (1980). The Statistical Analysis of Failure Time Data. Wiley, New York.
30. Karlin, s. and Taylor, H. M. (1975). A First Course in Stochastic Processes. Academic Press, New York.
31. Korn, E. L., Midthune, D., Chen, T. T., Rubinstein, L. V., Christian, M. C. and Simon, R. M. (1994). A comparison of two phase I trial designs. Statistics in Medicine 13 1799-1806.
32. Li, W. (1995). Sequential designs for opposing failure functions. Ph.D. dissertation, College of Arts and Sciences, American Univ., Washington.
33. Mantel, N. (1966). Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Reports 50 163-170.
34. O’quigley, J. (1992). Estimating the probability of a toxicity at the recommended dose following a phase I clinical trial in cancer. Biometrics 48 853-862.
35. O’Quigley, J. and Chevret, S. (1991). Methods for dose finding studies in cancer clinical trials: a review and results of a Monte Carlo study Statistics in Medicine 10 1647-1664.
36. O’Quigley, J., Pepe, M. and Fisher, L. (1990). Continual reassessment method: a practical design for phase I clinical trials in cancer. Biometrics 46 33-48.
37. Robbins, H. (1952). Some aspects of the sequential design of experiments. Bull. Amer. Math. Soc. 58 527-535.
38. Robbins, H. and Monro, s. (1951). A stochastic approximation method. Ann. Math. Statist. 29 400-407.
39. Rosenberger, W. F. (1992). Asymptotic inference problems arising from clinical trials using response-adaptive treatment allocation. Ph.D. dissertation, Graduate School of Arts and Sciences, George Washington Univ.
40. Rosenberger, W. F. (1993). Asymptotic inference with response-adaptive treatment allocation designs. Ann. Statist. 21 2098-2107.
41. Rosenberger, W. F., Flournoy, N. and Durham, s. D. (1996). Asymptotic normality of maximum likelihood estimators from multiparameter response-driven designs. J. Statist. Plann. Inference. 55.
42. Rosenberger, W. F. and Grill, S. (1996). A randomized sequential design for threshold experiments. Revised for Statistics in Medicine.
43. Rosenberger, W. F. and Lachin, J. M. (1993). The use of response-adaptive designs in clinical trials. Controlled Clinical Trials 14 471-484.
44. Rosenberger, W. F. and Sriram, T. N. (1996). Estimation for an adaptive allocation design. J. Statist. Plann. Inference. 55.
45. Royall, R. M. (1991). Ethics and statistics in randomized clinical trials (with discussion). Statist. Sci. 6 52-62.
46. Russek-Cohen, E. and Simon, R. M. (1994). Selecting the best dose when a monotonic dose-response relation exists. Statistics in Medicine 13 87-95.
47. Schmoor, C. and Schumacher, M. (1992). Adaptive statistical procedures for the analysis of nonmonotone dose-response relationships. Biometrie und Informatik in Medizin und Biologie 23 113-126.
48. Smythe, R. T. (1996). Central limit theorems for urn models. Stochastic Process. Appl. To appear.
49. Storer, B. E. (1989). Design and analysis of phase I clinical trials. Biometrics 45 925-937.
50. Tamura, R. N., Faries, D. E., Andersen, J. S. and Heiligenstein, J. H. (1994). A case study of an adaptive clinical trial in the treatment of out-patients with depressive disorder. J. Amer. Statist. Assoc. 89 768-776.
51. Temple, R. (1981). Government viewpoint of clinical trials. Drug Information Journal 16 10-17.
52. Tsutakawa, R. K. (1980). Selection of dose levels for estimating a percent point of a quantal response curve. J. Roy. Statist. Soc. Ser. C 29 25-33.
53. Wei, L. J. (1979). The generalized Polya urn design for sequential medical trials. Ann. Statist. 7 291-296.
54. Wei, L. J. (1988). Exact two-sample permutation tests based on the randomized play-the-winner rule. Biometrika 75 603-606.
55. Wei, L. J. and Durham, S. (1978). The randomized play-the-winner rule in medical trials. J. Amer. Statist. Assoc. 73 840-843.
56. Wei, L. J., Smythe, R. T., Lin, D. Y. and Park, T. S. (1990). Statistical inference with data-dependent treatment allocation rules. J. Amer. Statist. Assoc. 85 156-162.
57. Wu, C. F. J. (1985). Efficient sequential designs with binary data. J. Amer. Statist. Assoc. 80 974-984.
58. Yao, Q. and Wei, L. J. (1996). Play the winner for phase II/III clinical trials. Statistics in Medicine. To appear.
59. Zelen, M. (1969). Play the winner rule and the controlled clinical trial. J. Amer. Statist. Assoc. 64 131-146.
60. Zelen, M. and Wei, L. J. (1995). Foreword. In Adaptive Designs (N. Flournoy and W. F. Rosenberger, eds.). IMS, Hayward, CA.